5+2(İDARUBİSİN) PROTOKOLÜ

Kaynaklar:

1- Creutzig, U., M. M. van den Heuvel-Eibrink, B. Gibson, et al. 2012. "Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel." Blood 120(16):3187-3205.

2- Mayer, R. J., R. B. Davis, C. A. Schiffer, et al. 1994. "Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B." N.Engl.J.Med. 331(14):896-903.

3- Berman, E., G. Heller, J. Santorsa, et al. 1991. "Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia." Blood 77(8):1666-1674.

4- Creutzig, U., M. M. van den Heuvel-Eibrink, B. Gibson, et al. 2012. "Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel." Blood 120(16):3187-3205.